Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7

Dermatology

Volumn 213, Issue 4, 2006, Pages 341-344

  Yagami, Akiko ^a   Yoshikawa, Tetsushi ^a   Asano, Yoshizo ^a   Koie, Shin ^a   Shiohara, Tetsuo ^b   Matsunaga, Kayoko ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYORIN UNIVERSITY   (Japan)

Author keywords

Drug induced hypersensitivity syndrome; Human herpesvirus 7; Mexiletine hydrochloride

Indexed keywords

IMMUNOGLOBULIN G; MEXILETINE; VIRUS DNA;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; FEVER; HEART FAILURE; HEPATITIS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; LYMPHADENOPATHY; LYMPHOCYTOSIS; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SKIN CULTURE; STEROID THERAPY; VIRUS REACTIVATION;

ANTI-ARRHYTHMIA AGENTS; ANTIBODIES, VIRAL; DNA, VIRAL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTOSIS; MALE; MEXILETINE; MIDDLE AGED; ROSEOLOVIRUS INFECTIONS; SYNDROME; VIRUS ACTIVATION;

EID: 33751529200     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096200     Document Type: Article

References (31)

1. Shear N, Spielberg SP: Anticonvulsant hypersensitivity syndrome. In vitro assesment of risk. J Clin Invest 1988;82:1826-1832.
2. Tas S, Simonart T: Management of drug rash with eosinophilia and systemic symptoms (DRESS): an update. Dermatology 2003;206:353-356.
3. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T: Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998;134:1108-1112.
4. Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, Hashimoto K: Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998;134:1113-1117.
5. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T: Identification of human herpesvirus 6 as a causal agent for exanthem subitum. Lancet 1988;i:1065-1067.
6. Asano Y, Yoshikawa T, Suga S, Yazaki T, Hata T, Nagai T, Kajita Y, Ozaki T, Yoshida S: Viremia and neutralizing antibody response in infants with exanthem subitum. J Pediatr 1989;114:535-539.
7. Yoshikawa T, Suga S, Asano Y, Yazaki T, Kodama H, Ozaki T: Distribution of antibodies to a causative agent of exanthem subitum (human herpesvirus 6) in healthy individuals. Pediatrics 1989;84:675-677.
8. Yoshikawa T, Suga S, Asano Y, Nakashima T, Yazaki T, Sobue R, Hirano M, Fukuda M, Kojima S, Matsuyama T: Human herpesvirus 6 infection in bone marrow transplantation. Blood 1991;78:1381-1384.
9. Yoshikawa T, Suga S, Asano Y, Nakashima T, Yazaki T, Ono Y, Fujita T, Tsuzuki K, Sugiyama S, Oshima S: A prospective study of hu man herpesvirus 6 infection in renal transplantation. Transplantation 1992;54:879-883.
10. Akashi K, Eizuru Y, Sumiyoshi Y, Minematsu T, Hara S, Harada M, Kikuchi M, Niho Y, Minamishima Y: Severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 1993;329:168-171.
11. Frenkel N, Schirmer EC, Wyatt LS, Katsafanas G, Roffman E, Danovich RM, June CH: Isolation of a new herpesvirus from human CD4+ T cells. Proc Natl Acad Sci USA 1990;87:748-752.
12. Wyatt LS, Rodriguez WJ, Balachandran N, Frenke N: Human herpesvirus 7: antigenic properties and prevalence in children and adults. J Virol 1991;65:6260-6265.
13. Yoshikawa T, Asano Y, Kobayashi I, Nakashima T, Yazaki T, Suga S, Ozaki T, Wyatt LS, Frenkel N: Seroepidemiology of human herpesvirus 7 in healthy children and adults in Japan. J Med Virol 1993;41:319-323.
14. Ueda K, Kusuhara K, Okada K, Miyazaki C, Hidaka Y, Tokugawa K, Yamanishi K: Primary human herpesvirus 7 infection and exanthema subitum. Pediatr Infect Dis J 1994;13:167-168.
15. Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T, Yamanishi K: Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J Pediatr 1994;125:1-5.
16. Suga S, Yoshikawa T, Nagai T, Asano Y: Clinical features and virological findings in children with primary human herpesvirus 7 infection. Pediatrics 1997;99:E4.
17. Torigoe S, Koide W, Yamada M, Miyashiro E, Tanaka-Taya K, Yamanishi K: Human herpesvirus 7 infection associated with central nervous system manifestations. J Pediatr 1996;129:301-305.
18. Hashida T, Komura E, Yoshida M, Otsuka T, Hibi S, Imashuku S, Ishizaki T, Yamada A, Suga S, Asano Y: Hepatitis in association with human herpesvirus-7 infection. Pediatrics 1995;96:783-785.
19. Drago F, Ranieri E, Malaguti F, Battifoglio ML, Losi E, Rebora A: Human herpesvirus 7 in patients with pityriasis rosea. Dermatology 1997;195:374-378.
20. Hara H, Kobayashi M, Yokoyama A, Tochigi M, Matsunaga A, Shimizu H, Goshima J, Suzuki H: Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7. Dermatology 2005;211:159-161.
21. Aubin JT, Collandre H, Candotti D, Ingrand D, Rouzioux C, Burgard M, Richard S, Huraux JM, Agut H: Several groups among human herpesvirus 6 strains can be distinguished by southern blotting and polymerase chain reaction. J Clin Microbiol 1991;29:367-372.
22. Berneman ZN, Ablashi DV, Li G, Eger-Fletcher M, Reitz MS, Hung CL, Brus I, Komaroff AL, Gallo RC: Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci USA 1992;89:10552-10556.
23. Yoshikawa T, Ihira M, Suzuki K, Suga S, Asano Y, Asomura K, Tanaka K, Nishiyama Y: Primary human herpesvirus 6 infection in liver transplant recipients. J Pediatr 2001;138:921-925.
24. Yoshikawa T, Ihira M, Ohashi M, Suga S, Asano Y, Miyazaki H, Hirano M, Suzuki K, Matsunaga K, Horibe K, Kojima S, Kudo K, Kato K, Matsuyama T, Nishiyama Y: Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001;28:77-81.
25. Suga S, Yoshikawa T, Kajita Y, Ozaki T, Asano Y: Prospective study of persistence and excretion of human herpesvirus 6 in patients with exanthem subitum and their parents. Pediatrics 1998;102:900-904.
26. Kempf W, Adams V, Mirandola P, Menotti L, Luca DD, Wey N, Muller B, Campadelli-Fiume G: Persistence of human herpesvirus 7 in normal tissues detected by expression of a structural antigen. J Infect Dis 1998;178:841-845.
27. Hasegawa H, Utsunomiya Y, Yasukawa M, Yanagisawa K, Fujita S: Induction of G protein-coupled peptide receptor EBI 1 by human herpesvirus 6 and 7 infection in CD4+ T cells. J Virol 1994;68:5326-5329.
28. Tas S, Simonart T: Herpesviruses in patients with drug hypersensitivity syndrome: culprits, cofactors or innocent bystanders? Dermatology 2006;213:273-276.
29. Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S, Crickx B: Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003;148:1032-1034.
30. Mitani N, Aihara M, Yamakawa Y, Yamada M, Itoh N, Mizuki N, Ikezawa Z: Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses. J Med Virol 2005;75:430-434.
31. Janela B, Descamps V, Picard D, Rogez S, D'Incan M, Bernard P, Chevrant-Breton J, Milipied B, Bonnetblanc JM, Barbaud A, Dupin N, Doutre MS, Jacquot S, Roujeau JC, Tron F, Joly P, Musette P: Rôle des réactivations virales sur la réponse lymphocytaire T au cours du syndrome d'hypersensibilité médicamenteuse. Ann Dermatol Vénéréol 2005;132:37.